BEIJING LABTECH INSTRUMENTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.69 CNY | +3.59% |
|
+4.77% | -23.34% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,137 | 4,313 | 2,722 | 2,253 | 1,727 | - | - |
| Enterprise Value (EV) 1 | 2,137 | 4,313 | 2,722 | 2,253 | 1,727 | 1,727 | 1,727 |
| P/E ratio | 26.1 x | 61.9 x | 60.4 x | 81.7 x | 30.4 x | 24.8 x | 24.9 x |
| Yield | - | 0.54% | 0.49% | 2.39% | - | 0.76% | - |
| Capitalization / Revenue | 6.12 x | 11.7 x | 7.67 x | 5.42 x | 3.65 x | 3.05 x | 2.77 x |
| EV / Revenue | 6.12 x | 11.7 x | 7.67 x | 5.42 x | 3.65 x | 3.05 x | 2.77 x |
| EV / EBITDA | - | - | 45.4 x | 53.1 x | 36.8 x | 25.4 x | 21.3 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | 5.48 x | 3.29 x | 2.65 x | 1.96 x | 1.8 x | 1.73 x |
| Nbr of stocks (in thousands) | 67,000 | 67,000 | 67,236 | 67,236 | 67,236 | - | - |
| Reference price 2 | 31.89 | 64.38 | 40.48 | 33.51 | 25.69 | 25.69 | 25.69 |
| Announcement Date | 2/24/21 | 2/24/22 | 2/14/23 | 2/24/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 348.8 | 368.9 | 355 | 416 | 473 | 566 | 623 |
| EBITDA 1 | - | - | 59.96 | 42.46 | 47 | 68 | 81 |
| EBIT 1 | - | 76.98 | 51.29 | 28.47 | 64.5 | 80 | 76 |
| Operating Margin | - | 20.87% | 14.45% | 6.84% | 13.64% | 14.13% | 12.2% |
| Earnings before Tax (EBT) 1 | - | - | 51.19 | 28.43 | 84 | 80.5 | 76 |
| Net income 1 | - | 69.41 | 44.62 | 27.56 | 72.99 | 69.27 | 69 |
| Net margin | - | 18.82% | 12.57% | 6.63% | 15.43% | 12.24% | 11.08% |
| EPS 2 | 1.220 | 1.040 | 0.6700 | 0.4100 | 1.090 | 1.035 | 1.030 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | 0.3500 | 0.2000 | 0.8000 | 0.3300 | 0.3900 | - |
| Announcement Date | 2/24/21 | 2/24/22 | 2/14/23 | 2/24/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 9.1% | 5.55% | 3.29% | 5.86% | 6.69% | 5.6% |
| ROA (Net income/ Total Assets) | - | 7.96% | 5.01% | - | 4.6% | 6.05% | 6.9% |
| Assets 1 | - | 872.4 | 890.8 | - | 1,239 | 1,145 | 1,000 |
| Book Value Per Share 2 | - | 11.70 | 12.30 | 12.60 | 13.10 | 14.30 | 14.90 |
| Cash Flow per Share 2 | - | 0.7300 | 0.1100 | 0.6300 | 0.8300 | 0.5400 | 0.6600 |
| Capex 1 | - | 77.4 | 27.5 | 26.4 | 45 | 44 | 51 |
| Capex / Sales | - | 21% | 7.73% | 6.34% | 9.51% | 7.77% | 8.19% |
| Announcement Date | 2/24/21 | 2/24/22 | 2/14/23 | 2/24/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
25.69
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.34% | 239M | |
| +9.94% | 8.32B | |
| -3.49% | 4.71B | |
| -7.67% | 2.89B | |
| +5.57% | 2.2B | |
| -24.33% | 1.16B | |
| -4.02% | 893M | |
| -10.37% | 794M | |
| -16.28% | 825M | |
| -55.76% | 702M |
- Stock Market
- Equities
- 688056 Stock
- Financials Beijing Labtech Instruments Co., Ltd.